Insulin aspart
Novolog (insulin aspart) is a fast-acting insulin analog used to control blood sugar in people with diabetes. It's injected subcutaneously or intravenously, available in pens, syringes, and vials at 100 units/mL strength. Manufactured by Novo Nordisk, it's prescribed for managing type 1 or 2 diabetes. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Novolog (insulin aspart) is a fast-acting insulin analog used to control blood sugar in people with diabetes. It's injected subcutaneously or intravenously, available in pens, syringes, and vials at 100 units/mL strength. Manufactured by Novo Nordisk, it's prescribed for managing type 1 or 2 diabetes. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Insulin aspart",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Insulin aspart — ANDA 020986 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020986"
}
]
|
| identifier | ANDA020986 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"fda",
"health-care",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Insulin aspart |
